Related Experiment Video

Updated: Aug 15, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

[A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]

K Maeda1, T Teranishi, T Majima

  • 1Department of Internal Medicine II, Nara Medical University, Japan.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|December 14, 1999
PubMed

Insights

Common Variable Immunodeficiency (CVID) patients with persistent sinopulmonary infections may benefit from long-term erythromycin (EM) chemotherapy when standard immunoglobulin therapy fails. This approach can effectively manage refractory respiratory symptoms and Pseudomonas aeruginosa infections.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • Common Variable Immunodeficiency (CVID) is characterized by impaired antibody production, leading to recurrent sinopulmonary infections.
  • Sinopulmonary infections are the primary cause of morbidity and mortality in CVID patients.
  • Intravenous immunoglobulin (IVIG) therapy is the standard treatment, but some patients develop refractory infections.

Observation:

  • A 32-year-old female CVID patient presented with persistent sinopulmonary infection (purulent sputum, cough, nasal obstruction) refractory to IVIG.
  • Chest X-ray revealed bronchiectasis in both lung bases.
  • Sputum culture identified Pseudomonas aeruginosa.

Findings:

  • Long-term chemotherapy with erythromycin (EM) was initiated for the patient.
  • The patient experienced gradual resolution of respiratory symptoms following EM treatment.
  • This suggests EM chemotherapy can be effective in managing IVIG-refractory sinopulmonary infections in CVID.

Implications:

  • Long-term EM chemotherapy presents a viable treatment option for CVID patients with refractory sinopulmonary infections.
  • This case highlights the importance of considering alternative or adjunctive therapies beyond IVIG for complex CVID-related respiratory issues.
  • Further research into the efficacy and optimal duration of EM therapy in CVID is warranted.

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...